MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TRVN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Trevena (TRVN) Ownership - Who owns Trevena?

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.67K
P/E Ratio
N/A
Total Cash
16.37M
Projected Growth
N/A
Total Debt
36.47M
Revenue
443K
Risk (Beta)
-3.07
Dividend Yield
N/A
Total Cash/Share
18.95
Total Debt/Equity
N/A
Revenue/Share
0.63 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for TRVN
Related Blogs
UPB

Why Is Upstream Bio (UPB) Stock Down -8.70% Today?

IBRX

Why Is ImmunityBio (IBRX) Stock Down -9.26% Today?

MANE

Veradermics (MANE): Key Data Readouts and Regulatory Path for Oral Hair-Loss Candidate

BNTC

Why Is Benitec Biopharma (BNTC) Stock Down -3.76% Today?

LABT

Why Is Lakewood-Amedex Biotherapeutics (LABT) Stock Down -34.93% Today?

View all blogs related to
#Biotechnology
Interesting Articles

What does price to tangible book value (PTBV) mean?

What is a commodities futures contract?

What are ICOs?

What are the fundamental principles of stock trading?

What Is a Liability?

View all articles
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics products

Industry Biotechnology

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A